tiprankstipranks
Mural Oncology Plc (MURA)
NASDAQ:MURA
US Market
Holding MURA?
Track your performance easily

Mural Oncology Plc (MURA) Income Statement

410 Followers

Mural Oncology Plc Income Statement

Last quarter (Q3 2024), Mural Oncology Plc's total revenue was $―, a decrease of ― from previous quarter. In Q3, Mural Oncology Plc's net income was $-31.76M. See Mural Oncology Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 196.24M
Operating Income
$ -196.24M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -951.00K
Pretax Income
$ -195.29M
Tax Provision
$ 12.16M
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -207.45M
Basic EPS
$ -12.43
Diluted EPS
$ -12.43
Basic Average Shares
$ 16.69M
Diluted Average Shares
$ 16.69M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 196.24M
Net Income From Continuing And Discontinued Operation
$ -207.45M
Normalized Income
-
Interest Expense
-
EBIT
$ -195.29M
EBITDA
$ -192.69M
Currency in USD

Mural Oncology Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis